APO Research
Talk to an analyst

APO RESEARCH · REPORT

Escherichia Coli Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Escherichia Coli Testing Market Outlook and Growth Opportunities 2026

1 January 2026215 pages

Choose your research edition.

Industry ResearchEscherichia Coli Testing Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Escherichia Coli Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Escherichia Coli Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Escherichia Coli Testing Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Escherichia Coli Testing Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Escherichia Coli Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Escherichia Coli Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Escherichia Coli Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Escherichia Coli Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Escherichia Coli Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Escherichia Coli Testing market include Abbott, BD, BioMerieux, Novartis, Olympus Corporation, Lonza Group, Merck, Johnson & Johnson and Danaher Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Escherichia Coli Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Escherichia Coli Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Escherichia Coli Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Escherichia Coli Testing market.

Escherichia Coli Testing Segment by Company

Abbott

BD

BioMerieux

Novartis

Olympus Corporation

Lonza Group

Merck

Johnson & Johnson

Danaher Corporation

Thermo Fisher Scientific

GE Healthcare

Fujifilm

Corning

Enzo Life Sciences

Hologic

Idexx Laboratories

Meridian Bioscience

SSI Diagnostica

Bio Rad Laboratories

HiMedia Laboratories

RAKIRO BIOTECH SYSTEMS

Cell Culture Technologies

Caisson Laboratories

Escherichia Coli Testing Segment by Type

Environmental Testing

Clinical Testing

Escherichia Coli Testing Segment by Application

Diagnostic Laboratories and Hospital

Waste Water Treatment Organizations

Water Suppliers

Research Laboratories

Government Agencies

Others

Escherichia Coli Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Escherichia Coli Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Escherichia Coli Testing key companies, revenue, market share, and recent developments.

3. To split the Escherichia Coli Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Escherichia Coli Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Escherichia Coli Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Escherichia Coli Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Escherichia Coli Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Escherichia Coli Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Escherichia Coli Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Escherichia Coli Testing industry.

Chapter 3: Detailed analysis of Escherichia Coli Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Escherichia Coli Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Escherichia Coli Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Escherichia Coli Testing Industry Trends Table 2. Escherichia Coli Testing Industry Drivers Table 3. Escherichia Coli Testing Industry Opportunities and Challenges Table 4. Escherichia Coli Testing Industry Restraints Table 5. Global Escherichia Coli Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Escherichia Coli Testing Revenue Share by Company (2021-2026) Table 7. Global Escherichia Coli Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Escherichia Coli Testing Key Company Manufacturing Base & Headquarters Table 9. Global Escherichia Coli Testing Company, Product Type & Application Table 10. Global Escherichia Coli Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Escherichia Coli Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Environmental Testing Table 15. Significant Companies of Clinical Testing Table 16. Global Escherichia Coli Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Escherichia Coli Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Escherichia Coli Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Escherichia Coli Testing Sales Value Share by Type (2021-2026) Table 20. Global Escherichia Coli Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diagnostic Laboratories and Hospital Table 22. Significant Companies of Waste Water Treatment Organizations Table 23. Significant Companies of Water Suppliers Table 24. Significant Companies of Research Laboratories Table 25. Significant Companies of Government Agencies Table 26. Significant Companies of Others Table 27. Global Escherichia Coli Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Escherichia Coli Testing Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Escherichia Coli Testing Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Escherichia Coli Testing Sales Value Share by Application (2021-2026) Table 31. Global Escherichia Coli Testing Sales Value Share by Application (2027-2032) Table 32. Global Escherichia Coli Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Escherichia Coli Testing Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Escherichia Coli Testing Sales Value Share by Region (2021-2026) Table 35. Global Escherichia Coli Testing Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Escherichia Coli Testing Sales Value Share by Region (2027-2032) Table 37. Global Escherichia Coli Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Escherichia Coli Testing Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Escherichia Coli Testing Sales Value Market Share by Country (2021-2026) Table 40. Global Escherichia Coli Testing Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Escherichia Coli Testing Sales Value Market Share by Country (2027-2032) Table 42. Abbott Company Information Table 43. Abbott Business Overview Table 44. Abbott Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Abbott Escherichia Coli Testing Product Portfolio Table 46. Abbott Recent Development Table 47. BD Company Information Table 48. BD Business Overview Table 49. BD Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. BD Escherichia Coli Testing Product Portfolio Table 51. BD Recent Development Table 52. BioMerieux Company Information Table 53. BioMerieux Business Overview Table 54. BioMerieux Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BioMerieux Escherichia Coli Testing Product Portfolio Table 56. BioMerieux Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Novartis Escherichia Coli Testing Product Portfolio Table 61. Novartis Recent Development Table 62. Olympus Corporation Company Information Table 63. Olympus Corporation Business Overview Table 64. Olympus Corporation Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Olympus Corporation Escherichia Coli Testing Product Portfolio Table 66. Olympus Corporation Recent Development Table 67. Lonza Group Company Information Table 68. Lonza Group Business Overview Table 69. Lonza Group Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lonza Group Escherichia Coli Testing Product Portfolio Table 71. Lonza Group Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Escherichia Coli Testing Product Portfolio Table 76. Merck Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Escherichia Coli Testing Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Danaher Corporation Company Information Table 83. Danaher Corporation Business Overview Table 84. Danaher Corporation Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Danaher Corporation Escherichia Coli Testing Product Portfolio Table 86. Danaher Corporation Recent Development Table 87. Thermo Fisher Scientific Company Information Table 88. Thermo Fisher Scientific Business Overview Table 89. Thermo Fisher Scientific Escherichia Coli Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Thermo Fisher Scientific Escherichia Coli Testing Product Portfolio Table 91. Thermo Fisher Scientific Recent Development Table 92. GE Healthcare Company Information Table 93. GE Healthcare Business Overview Table 94. GE Healthcare Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GE Healthcare Escherichia Coli Testing Product Portfolio Table 96. GE Healthcare Recent Development Table 97. Fujifilm Company Information Table 98. Fujifilm Business Overview Table 99. Fujifilm Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Fujifilm Escherichia Coli Testing Product Portfolio Table 101. Fujifilm Recent Development Table 102. Corning Company Information Table 103. Corning Business Overview Table 104. Corning Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Corning Escherichia Coli Testing Product Portfolio Table 106. Corning Recent Development Table 107. Enzo Life Sciences Company Information Table 108. Enzo Life Sciences Business Overview Table 109. Enzo Life Sciences Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Enzo Life Sciences Escherichia Coli Testing Product Portfolio Table 111. Enzo Life Sciences Recent Development Table 112. Hologic Company Information Table 113. Hologic Business Overview Table 114. Hologic Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hologic Escherichia Coli Testing Product Portfolio Table 116. Hologic Recent Development Table 117. Idexx Laboratories Company Information Table 118. Idexx Laboratories Business Overview Table 119. Idexx Laboratories Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Idexx Laboratories Escherichia Coli Testing Product Portfolio Table 121. Idexx Laboratories Recent Development Table 122. Meridian Bioscience Company Information Table 123. Meridian Bioscience Business Overview Table 124. Meridian Bioscience Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Meridian Bioscience Escherichia Coli Testing Product Portfolio Table 126. Meridian Bioscience Recent Development Table 127. SSI Diagnostica Company Information Table 128. SSI Diagnostica Business Overview Table 129. SSI Diagnostica Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. SSI Diagnostica Escherichia Coli Testing Product Portfolio Table 131. SSI Diagnostica Recent Development Table 132. Bio Rad Laboratories Company Information Table 133. Bio Rad Laboratories Business Overview Table 134. Bio Rad Laboratories Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bio Rad Laboratories Escherichia Coli Testing Product Portfolio Table 136. Bio Rad Laboratories Recent Development Table 137. HiMedia Laboratories Company Information Table 138. HiMedia Laboratories Business Overview Table 139. HiMedia Laboratories Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. HiMedia Laboratories Escherichia Coli Testing Product Portfolio Table 141. HiMedia Laboratories Recent Development Table 142. RAKIRO BIOTECH SYSTEMS Company Information Table 143. RAKIRO BIOTECH SYSTEMS Business Overview Table 144. RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Product Portfolio Table 146. RAKIRO BIOTECH SYSTEMS Recent Development Table 147. Cell Culture Technologies Company Information Table 148. Cell Culture Technologies Business Overview Table 149. Cell Culture Technologies Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Cell Culture Technologies Escherichia Coli Testing Product Portfolio Table 151. Cell Culture Technologies Recent Development Table 152. Caisson Laboratories Company Information Table 153. Caisson Laboratories Business Overview Table 154. Caisson Laboratories Escherichia Coli Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Caisson Laboratories Escherichia Coli Testing Product Portfolio Table 156. Caisson Laboratories Recent Development Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Escherichia Coli Testing Product Image Figure 2. Global Escherichia Coli Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Escherichia Coli Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Escherichia Coli Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Environmental Testing Image Figure 8. Clinical Testing Image Figure 9. Global Escherichia Coli Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Escherichia Coli Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Escherichia Coli Testing Sales Value Share by Type (2021-2032) Figure 12. Diagnostic Laboratories and Hospital Image Figure 13. Waste Water Treatment Organizations Image Figure 14. Water Suppliers Image Figure 15. Research Laboratories Image Figure 16. Government Agencies Image Figure 17. Others Image Figure 18. Global Escherichia Coli Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Escherichia Coli Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Escherichia Coli Testing Sales Value Share by Application (2021-2032) Figure 21. Global Escherichia Coli Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Escherichia Coli Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Escherichia Coli Testing Sales Value (2021-2032) & (US$ Million) Figure 24. North America Escherichia Coli Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Escherichia Coli Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Escherichia Coli Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Escherichia Coli Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Escherichia Coli Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Escherichia Coli Testing Sales Value (2021-2032) & (US$ Million) Figure 30. South America Escherichia Coli Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Escherichia Coli Testing Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Escherichia Coli Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Escherichia Coli Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Environmental Testing
  • Clinical Testing
Applications
  • Diagnostic Laboratories and Hospital
  • Waste Water Treatment Organizations
  • Water Suppliers
  • Research Laboratories
  • Government Agencies
  • Others
Companies covered
  • Abbott
  • BD
  • BioMerieux
  • Novartis
  • Olympus Corporation
  • Lonza Group
  • Merck
  • Johnson & Johnson
  • Danaher Corporation
  • Thermo Fisher Scientific
  • GE Healthcare
  • Fujifilm
  • Corning
  • Enzo Life Sciences
  • Hologic
  • Idexx Laboratories
  • Meridian Bioscience
  • SSI Diagnostica
  • Bio Rad Laboratories
  • HiMedia Laboratories
  • RAKIRO BIOTECH SYSTEMS
  • Cell Culture Technologies
  • Caisson Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Escherichia Coli Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Escherichia Coli Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Escherichia Coli Testing Market Dynamics
  1. 2.1 Escherichia Coli Testing Industry Trends
  2. 2.2 Escherichia Coli Testing Industry Drivers
  3. 2.3 Escherichia Coli Testing Industry Opportunities and Challenges
  4. 2.4 Escherichia Coli Testing Industry Restraints
3 Escherichia Coli Testing Market by Company
  1. 3.1 Global Escherichia Coli Testing Company Revenue Ranking in 2025
  2. 3.2 Global Escherichia Coli Testing Revenue by Company (2021-2026)
  3. 3.3 Global Escherichia Coli Testing Company Ranking (2024-2026)
  4. 3.4 Global Escherichia Coli Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Escherichia Coli Testing Company Product Type and Application
  6. 3.6 Global Escherichia Coli Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Escherichia Coli Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Escherichia Coli Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Escherichia Coli Testing Market by Type
  1. 4.1 Escherichia Coli Testing Type Introduction
  2. 4.1.1 Environmental Testing
  3. 4.1.2 Clinical Testing
  4. 4.2 Global Escherichia Coli Testing Sales Value by Type
  5. 4.2.1 Global Escherichia Coli Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Escherichia Coli Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Escherichia Coli Testing Sales Value Share by Type (2021-2032)
5 Escherichia Coli Testing Market by Application
  1. 5.1 Escherichia Coli Testing Application Introduction
  2. 5.1.1 Diagnostic Laboratories and Hospital
  3. 5.1.2 Waste Water Treatment Organizations
  4. 5.1.3 Water Suppliers
  5. 5.1.4 Research Laboratories
  6. 5.1.5 Government Agencies
  7. 5.1.6 Others
  8. 5.2 Global Escherichia Coli Testing Sales Value by Application
  9. 5.2.1 Global Escherichia Coli Testing Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Escherichia Coli Testing Sales Value by Application (2021-2032)
  11. 5.2.3 Global Escherichia Coli Testing Sales Value Share by Application (2021-2032)
6 Escherichia Coli Testing Regional Value Analysis
  1. 6.1 Global Escherichia Coli Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Escherichia Coli Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Escherichia Coli Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Escherichia Coli Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Escherichia Coli Testing Sales Value (2021-2032)
  7. 6.3.2 North America Escherichia Coli Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Escherichia Coli Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Escherichia Coli Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Escherichia Coli Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Escherichia Coli Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Escherichia Coli Testing Sales Value (2021-2032)
  16. 6.6.2 South America Escherichia Coli Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Escherichia Coli Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Escherichia Coli Testing Sales Value Share by Country, 2025 VS 2032
7 Escherichia Coli Testing Country-level Value Analysis
  1. 7.1 Global Escherichia Coli Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Escherichia Coli Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Escherichia Coli Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Escherichia Coli Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Escherichia Coli Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Escherichia Coli Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Escherichia Coli Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Escherichia Coli Testing Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 BD
  8. 8.2.1 BD Company Information
  9. 8.2.2 BD Business Overview
  10. 8.2.3 BD Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BD Escherichia Coli Testing Product Portfolio
  12. 8.2.5 BD Recent Developments
  13. 8.3 BioMerieux
  14. 8.3.1 BioMerieux Company Information
  15. 8.3.2 BioMerieux Business Overview
  16. 8.3.3 BioMerieux Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioMerieux Escherichia Coli Testing Product Portfolio
  18. 8.3.5 BioMerieux Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Escherichia Coli Testing Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Olympus Corporation
  26. 8.5.1 Olympus Corporation Company Information
  27. 8.5.2 Olympus Corporation Business Overview
  28. 8.5.3 Olympus Corporation Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Olympus Corporation Escherichia Coli Testing Product Portfolio
  30. 8.5.5 Olympus Corporation Recent Developments
  31. 8.6 Lonza Group
  32. 8.6.1 Lonza Group Company Information
  33. 8.6.2 Lonza Group Business Overview
  34. 8.6.3 Lonza Group Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lonza Group Escherichia Coli Testing Product Portfolio
  36. 8.6.5 Lonza Group Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Escherichia Coli Testing Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 Johnson & Johnson
  44. 8.8.1 Johnson & Johnson Company Information
  45. 8.8.2 Johnson & Johnson Business Overview
  46. 8.8.3 Johnson & Johnson Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Johnson & Johnson Escherichia Coli Testing Product Portfolio
  48. 8.8.5 Johnson & Johnson Recent Developments
  49. 8.9 Danaher Corporation
  50. 8.9.1 Danaher Corporation Company Information
  51. 8.9.2 Danaher Corporation Business Overview
  52. 8.9.3 Danaher Corporation Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Danaher Corporation Escherichia Coli Testing Product Portfolio
  54. 8.9.5 Danaher Corporation Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific Escherichia Coli Testing Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
  61. 8.11 GE Healthcare
  62. 8.11.1 GE Healthcare Company Information
  63. 8.11.2 GE Healthcare Business Overview
  64. 8.11.3 GE Healthcare Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 GE Healthcare Escherichia Coli Testing Product Portfolio
  66. 8.11.5 GE Healthcare Recent Developments
  67. 8.12 Fujifilm
  68. 8.12.1 Fujifilm Company Information
  69. 8.12.2 Fujifilm Business Overview
  70. 8.12.3 Fujifilm Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fujifilm Escherichia Coli Testing Product Portfolio
  72. 8.12.5 Fujifilm Recent Developments
  73. 8.13 Corning
  74. 8.13.1 Corning Company Information
  75. 8.13.2 Corning Business Overview
  76. 8.13.3 Corning Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Corning Escherichia Coli Testing Product Portfolio
  78. 8.13.5 Corning Recent Developments
  79. 8.14 Enzo Life Sciences
  80. 8.14.1 Enzo Life Sciences Company Information
  81. 8.14.2 Enzo Life Sciences Business Overview
  82. 8.14.3 Enzo Life Sciences Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Enzo Life Sciences Escherichia Coli Testing Product Portfolio
  84. 8.14.5 Enzo Life Sciences Recent Developments
  85. 8.15 Hologic
  86. 8.15.1 Hologic Company Information
  87. 8.15.2 Hologic Business Overview
  88. 8.15.3 Hologic Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hologic Escherichia Coli Testing Product Portfolio
  90. 8.15.5 Hologic Recent Developments
  91. 8.16 Idexx Laboratories
  92. 8.16.1 Idexx Laboratories Company Information
  93. 8.16.2 Idexx Laboratories Business Overview
  94. 8.16.3 Idexx Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Idexx Laboratories Escherichia Coli Testing Product Portfolio
  96. 8.16.5 Idexx Laboratories Recent Developments
  97. 8.17 Meridian Bioscience
  98. 8.17.1 Meridian Bioscience Company Information
  99. 8.17.2 Meridian Bioscience Business Overview
  100. 8.17.3 Meridian Bioscience Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Meridian Bioscience Escherichia Coli Testing Product Portfolio
  102. 8.17.5 Meridian Bioscience Recent Developments
  103. 8.18 SSI Diagnostica
  104. 8.18.1 SSI Diagnostica Company Information
  105. 8.18.2 SSI Diagnostica Business Overview
  106. 8.18.3 SSI Diagnostica Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SSI Diagnostica Escherichia Coli Testing Product Portfolio
  108. 8.18.5 SSI Diagnostica Recent Developments
  109. 8.19 Bio Rad Laboratories
  110. 8.19.1 Bio Rad Laboratories Company Information
  111. 8.19.2 Bio Rad Laboratories Business Overview
  112. 8.19.3 Bio Rad Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bio Rad Laboratories Escherichia Coli Testing Product Portfolio
  114. 8.19.5 Bio Rad Laboratories Recent Developments
  115. 8.20 HiMedia Laboratories
  116. 8.20.1 HiMedia Laboratories Company Information
  117. 8.20.2 HiMedia Laboratories Business Overview
  118. 8.20.3 HiMedia Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 HiMedia Laboratories Escherichia Coli Testing Product Portfolio
  120. 8.20.5 HiMedia Laboratories Recent Developments
  121. 8.21 RAKIRO BIOTECH SYSTEMS
  122. 8.21.1 RAKIRO BIOTECH SYSTEMS Company Information
  123. 8.21.2 RAKIRO BIOTECH SYSTEMS Business Overview
  124. 8.21.3 RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 RAKIRO BIOTECH SYSTEMS Escherichia Coli Testing Product Portfolio
  126. 8.21.5 RAKIRO BIOTECH SYSTEMS Recent Developments
  127. 8.22 Cell Culture Technologies
  128. 8.22.1 Cell Culture Technologies Company Information
  129. 8.22.2 Cell Culture Technologies Business Overview
  130. 8.22.3 Cell Culture Technologies Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Cell Culture Technologies Escherichia Coli Testing Product Portfolio
  132. 8.22.5 Cell Culture Technologies Recent Developments
  133. 8.23 Caisson Laboratories
  134. 8.23.1 Caisson Laboratories Company Information
  135. 8.23.2 Caisson Laboratories Business Overview
  136. 8.23.3 Caisson Laboratories Escherichia Coli Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Caisson Laboratories Escherichia Coli Testing Product Portfolio
  138. 8.23.5 Caisson Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst